What is the catalog number for CLDN2 Antibody (Phospho-Tyr224)?

The catalog number for CLDN2 Antibody (Phospho-Tyr224) is OAAB02013-400UL.

What sizes are available for CLDN2 Antibody (Phospho-Tyr224)?

CLDN2 Antibody (Phospho-Tyr224) is available in the following size(s): 400 µL.

Is CLDN2 Antibody (Phospho-Tyr224) in stock?

CLDN2 Antibody (Phospho-Tyr224) is currently made to order / not held in immediate stock. Contact us for lead time.

CLDN2 Antibody (Phospho-Tyr224)

Product Specifications

CAS Number

9007-83-4

Gene Aliases

OAZON

Gene ID

9075

Swiss Prot

P57739

Accession Number

NP_065117

Reactivity

Human

Immunogen

This CLDN2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding Y224 of human CLDN2.

Clonality

Polyclonal

Type

Polyclonal Antibody

Applications

Assay Protocol

Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol

Concentration

Approximately 0.5mg/ml. Actual concentration varies with each lot.

Homology

Human

Format

Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.